1-(4-Methylphenyl)-3-{[(3-methylphenyl)methyl]sulfanyl}-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile

Catalog No. :
ACOPGB744
CAS No. :
439096-50-1
Molecular Formula :
C25H24N2S
Molecular Weight :
384.55

IUPAC Name:3-((3-methylbenzyl)thio)-1-(p-tolyl)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile

1-(4-Methylphenyl)-3-{[(3-methylphenyl)methyl]sulfanyl}-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$565.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Methylphenyl)-3-{[(3-methylphenyl)methyl]sulfanyl}-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile
IUPAC Name3-((3-methylbenzyl)thio)-1-(p-tolyl)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile
Molecular FormulaC25H24N2S
Molecular Weight384.55
SMILESN#CC1=C(SCC2=CC=CC(C)=C2)N=C(C3=CC=C(C)C=C3)C4=C1CCCC4
InChI KeySQCPNURFNDHRCJ-UHFFFAOYSA-N
Synonym3-[(3-METHYLBENZYL)SULFANYL]-1-(4-METHYLPHENYL)-5,6,7,8-TETRAHYDRO-4-ISOQUINOLINECARBONITRILE;1-(4-methylphenyl)-3-[(3-methylphenyl)methylsulfanyl]-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile;4-Isoquinolinecarbonitrile, 5,6,7,8-tetrahydro-1-(4-methylphenyl)-3-[[(3-methylphenyl)methyl]thio]-
CAS No.439096-50-1

Synthetic Route by SureRoute

1. ACOPGB744 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBMED835 route compound structure diagram
    ACBMED83525697-56-7 In Stock
  4. Then
  5. ACOPGB744 route product structure diagram
    ACOPGB744439096-50-1
Inquiry

2. ACOPGB744 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOPGB744 route product structure diagram
    ACOPGB744439096-50-1
Inquiry

Comments (0)